Quark Pharmaceuticals

Quark Pharmaceuticals, Inc., the world leader in novel therapeutic RNAi discovery and development, has the largest clinical-stage siRNA pipeline in the industry. The Company’s fully integrated drug development platform spans therapeutic target identification to drug development. Quark’s approach to delivery allows targeting of tissues and organs including the eye, kidney, ear, lung, skin, spinal cord and brain. Quark has three siRNA product candidates in clinical development in five different disease indications of which two are in pivotal Phase III studies. Quark’s Joint Venture in China, Kunshan Ribo-Quark Pharmaceutical Inc, and its strategic partner in India, Biocon Limited, are part of Quark’s worldwide clinical studies network. Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel.
Company Growth (employees)
Fremont, US
Size (employees)
72 (est)+15%
Quark Pharmaceuticals was founded in 1994 and is headquartered in Fremont, US

Key People at Quark Pharmaceuticals

Daniel Zurr

Daniel Zurr

President and CEO
Rami Skaliter

Rami Skaliter

Shai Erlich

Shai Erlich

Chief Development Officer

Quark Pharmaceuticals Office Locations

Quark Pharmaceuticals has an office in Fremont
Fremont, US (HQ)
6501 Dumbarton Circle.

Quark Pharmaceuticals Metrics

Summary Metrics

Founding Date


Total Funding

$37 m

Quark Pharmaceuticals Online Presence

Quark Pharmaceuticals Company Life

You may also be interested in